Observer reproducibility of results from a low-dose 123I- metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 40, Issue 10, 2013, Pages 1549-1557

  Pellegrino, Teresa ^a   Petretta, Mario ^b   De Luca, Serena ^c   Paolillo, Stefania ^b   Boemio, Antonio ^c   Carotenuto, Raffaella ^c   Petretta, Maria Piera ^b   Di Nuzzo, Carmine ^b   Perrone Filardi, Pasquale ^b   Cuocolo, Alberto ^b  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c IRCCS SDN   (Italy)

Author keywords

Low dose protocol; MIBG cardiac imaging; Planar; Reproducibility; Single photon emission computed tomography

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; COVIDIEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CARDIAC IMAGING; CLINICAL PROTOCOL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SCINTISCANNING; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; RADIATION DOSE; RECOMMENDED DRUG DOSE; REPRODUCIBILITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

3-IODOBENZYLGUANIDINE; AGED; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84885468229     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-013-2461-4     Document Type: Article

References (32)

1. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. J Am Coll Cardiol. 2009;54:1747-62.
2. Carrió I, Cowie MR, Yamazaki J, Udelson J, Camici PG. Cardiac sympathetic imaging with mIBG in heart failure. JACC Cardiovasc Imaging. 2010;3:92-100.
3. Perrone-Filardi P, Paolillo S, Dellegrottaglie S, Gargiulo P, Savarese G, Marciano C, et al. Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal. Heart. 2011;97:1828-33.
4. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010;55:2212-21.
5. Kuwabara Y, Tamaki N, Nakata T, Yamashina S, Yamazaki J. Determination of the survival rate in patients with congestive heart failure stratified by 123I-MIBG imaging: a meta-analysis from the studies performed in Japan. Ann Nucl Med. 2011;25:101-7.
6. Paul M, Wichter T, Kies P, Gerss J, Wollmann C, Rahbar K, et al. Cardiac sympathetic dysfunction in genotyped patients with arrhythmogenic right ventricular cardiomyopathy and risk of recurrent ventricular tachyarrhythmias. J Nucl Med. 2011;52:1559-65.
7. Veltman CE, Boogers MJ, Meinardi JE, Al Younis I, Dibbets-Schneider P, Van der Wall EE, et al. Reproducibility of planar (123)I-meta- iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure. Eur J Nucl Med Mol Imaging. 2012;39:1599-608.
8. Flotats A, Carrió I, Agostini D, Le Guludec D, Marcassa C, Schäfers M, et al. Proposal for standardization of 123I- metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging. 2010;37:1802-12.
9. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539-42.
10. de Vet HC, Terwee CB, Knol DL, Bouter LM. When to use agreement versus reliability measures. J Clin Epidemiol. 2006;59:1033-9.
11. Bonett DG. Sample size requirements for estimating intraclass correlations with desired precision. Stat Med. 2002;21:1331-5.
12. Patel AD, Iskandrian AE. MIBG imaging. J Nucl Cardiol. 2002;9:75-94.
13. Travin MI. Cardiac autonomic imaging with SPECT tracers. J Nucl Cardiol. 2013;20:128-43.
14. Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53). Ann ICRP. 1998; 28:1-126.
15. Kottner J, Audigé L, Brorson S, Donner A, Gajewski BJ, Hróbjartsson A, et al. Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed. J Clin Epidemiol. 2011;64:96-106.
16. Watson PF, Petrie A. Method agreement analysis: a review of correct methodology. Theriogenology. 2010;73:1167-79.
17. Bland JM, Altman DG. Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol. 2003;22:85-93.
18. Bland JM, Altman DG. Measurement error and correlation coefficients. BMJ. 1996;313:41-2.
19. Shoukri MM. Measures of interobserver agreement. Boca Raton: Chapman & Hall/CRC; 2004.
20. Batterham AM, George KP. Reliability in evidence-based clinical practice: a primer for allied health professionals. Phys Ther Sport. 2000;1:54-62.
21. Weir JP. Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. J Strength Cond Res. 2005;19:231-40.
22. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989;45:255-68.
23. Germano G, Kavanagh PB, Slomka PJ, Berman DS. Tracking a therapeutic response: how reliable are serial measurements of LV perfusion and function? J Nucl Cardiol. 2012;19:360-3.
24. Matsui T, Tsutamoto T, Maeda K, Kusukawa J, Kinoshita M. Prognostic value of repeated 123I-metaiodobenzylguanidine imaging in patients with dilated cardiomyopathy with congestive heart failure before and after optimized treatments - comparison with neurohumoral factors. Circ J. 2002;66:537-43.
25. Kasama S, Toyama T, Sumino H, Nakazawa M, Matsumoto N, Sato Y, et al. Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction. J Nucl Med. 2008;49:907-14.
26. Drakos SG, Athanasoulis T, Malliaras KG, Terrovitis JV, Diakos N, Koudoumas D, et al. Myocardial sympathetic innervation and long-term left ventricular mechanical unloading. JACC Cardiovasc Imaging. 2010;3:64-70.
27. Somsen GA, Verberne HJ, Fleury E, Righetti A. Normal values and within-subject variability of cardiac I-123 MIBG scintigraphy in healthy individuals: implications for clinical studies. J Nucl Cardiol. 2004;11:126-33.
28. Estorch M, Serra-Grima R, Flotats A, Marí C, Bernà L, Catafau A, et al. Myocardial sympathetic innervation in the athlete's sinus bradycardia: is there selective inferior myocardial wall denervation? J Nucl Cardiol. 2000;7:354-8.
29. Matsuo S, Nakajima K, Okuda K, Kawano M, Ishikawa T, Hosoya T, et al. Standardization of the heart-to-mediastinum ratio of 123I-labelled- metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera collimator combinations. Eur J Nucl Med Mol Imaging. 2009;36:560-6.
30. Verberne HJ, Feenstra C, de Jong WM, Somsen GA, van Eck-Smit BL, Busemann SE. Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: a phantom study. Eur J Nucl Med Mol Imaging. 2005;32:1100-7.
31. Nakajima K, Okuda K, Matsuo S, Yoshita M, Taki J, Yamada M, et al. Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study. Eur J Nucl Med Mol Imaging. 2012;39:113-9.
32. Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol. 2010;55:2769-77.